(Q52959904)

English

Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1.

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/11774277

Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1. (English)

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/11774277

1 reference

based on heuristic

inferred from title

Karsten Jürchott

6

object named as

Karsten Jürchott

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/11774277

author name string

Martin Janz

1

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/11774277

Nadia Harbeck

2

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/11774277

Peer Dettmar

3

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/11774277

Ursula Berger

4

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/11774277

Anja Schmidt

5

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/11774277

Manfred Schmitt

7

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/11774277

Hans-Dieter Royer

8

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/11774277

language of work or name

0 references

publication date

1 January 2002

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/11774277

International Journal of Cancer

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/11774277

97

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/11774277

278-282

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/11774277

3

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/11774277

Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

Biochemistry of multidrug resistance mediated by the multidrug transporter

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

A role for Y-box proteins in cell proliferation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

Enhancement of mdr1 gene expression in normal tissue adjacent to advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

Acidic and basic fibroblast growth factors in human breast tissue

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

Gene regulation by Y-box proteins: coupling control of transcription and translation.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

A novel growth-inducible gene that encodes a protein with a conserved cold-shock domain

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

Anthracycline resistance in breast cancer: clinical applications of current knowledge

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

Multidrug resistance in breast cancer--is the jury in yet?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

ERBB2 oncogene in human breast cancer and its clinical significance

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC)

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

P-glycoprotein--a marker of cancer-cell behavior

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

Enhanced coexpression of YB-1 and DNA topoisomerase II alpha genes in human colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

Differential gene expression in nasopharyngeal carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1610

21 January 2018

Identifiers

10.1002/IJC.1610

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/11774277

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/11774277

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52959904&oldid=1766255417"